ReviewJournal of cardiovascular translational research2025

CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.

Bin Gu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.